| 1 | IMP3, SNAI2, TAZ, WNT5B
|
| IMP3 Stabilization of WNT5B mRNA Facilitates TAZ Activation in Breast Cancer.
|
| Samanta S, Guru S, Elaimy AL, Amante JJ, Ou J, Yu J, Zhu LJ, Mercurio AM.
|
| Cell Rep 23(9):2559-2567. doi: 10.1016/j.celrep.2018.04.113.
2018
|
| 2 | BTHS, TAZ
|
| Barth syndrome cells display widespread remodeling of mitochondrial complexes without affecting metabolic flux distribution.
|
| Chatzispyrou IA, Guerrero-Castillo S, Held NM, Ruiter JPN, Denis SW, IJlst L, Wanders RJ, van Weeghel M, Ferdinandusse S, Vaz FM, Brandt U, Houtkooper RH.
|
| Biochim Biophys Acta Mol Basis Dis 1864(11):3650-3658. doi: 10.1016/j.bbadis.2018.08.041. Epub 2018 Sep 1.
2018
|
| 3 | ITCH, TAZ, YAP1, YOD1
|
| Deubiquitinase YOD1: The Potent Activator of YAP in Hepatomegaly and Liver Cancer.
|
| Kim Y, Jho EH.
|
| BMB Rep MB Rep. 2017 May 15. pii: 3845. [Epub ahead of print]
2017
|
| 4 | ITCH, TAZ, YAP1, YOD1
|
| Deubiquitinase YOD1 potentiates YAP/TAZ activities through enhancing ITCH stability.
|
| Kim Y, Kim W, Song Y, Kim JR, Cho K, Moon H, Ro SW, Seo E, Ryu YM, Myung SJ, Jho EH.
|
| Proc Natl Acad Sci U S A 114(18):4691-4696. doi: 10.1073/pnas.1620306114. Epub 2017 Apr 17.
2017
|
| 5 | TAZ
|
| Tafazzin (TAZ) promotes the tumorigenicity of cervical cancer cells and inhibits apoptosis.
|
| Chen M, Zhang Y, Zheng PS.
|
| PLoS One 12(5):e0177171. doi: 10.1371/journal.pone.0177171. eCollection 2017.
2017
|
| 6 | BTHS, TAZ
|
| Defining functional classes of Barth syndrome mutation in humans.
|
| Lu YW, Galbraith L, Herndon JD, Lu YL, Pras-Raves M, Vervaart M, Van Kampen A, Luyf A, Koehler CM, McCaffery JM, Gottlieb E, Vaz FM, Claypool SM.
|
| Hum Mol Genet 25(9):1754-70. doi: 10.1093/hmg/ddw046. Epub 2016 Feb 16.
2016
|
| 7 | BTHS, TAZ
|
| When silence is noise: infantile-onset Barth syndrome caused by a synonymous substitution affecting TAZ gene transcription.
|
| Ferri L, Dionisi-Vici C, Taurisano R, Vaz FM, Guerrini R, Morrone A.
|
| Clin Genet 90(5):461-465. doi: 10.1111/cge.12756. Epub 2016 Mar 4.
2016
|
| 8 | LATS1, PARD3, PPP1CA, TAZ
|
| PARD3 induces TAZ activation and cell growth by promoting LATS1 and PP1 interaction.
|
| Lv XB, Liu CY, Wang Z, Sun YP, Xiong Y, Lei QY, Guan KL.
|
| EMBO Rep 16(8):975-85. doi: 10.15252/embr.201439951. Epub 2015 Jun 26.
2015
|
| 9 | BTHS, TAZ
|
| Cardiolipin remodeling by TAZ/tafazzin is selectively required for the initiation of mitophagy.
|
| Hsu P, Liu X, Zhang J, Wang HG, Ye JM, Shi Y.
|
| Autophagy 11(4):643-52. doi: 10.1080/15548627.2015.1023984.
2015
|
| 10 | BTHS, TAZ
|
| Mitochondria-targeted antioxidant prevents cardiac dysfunction induced by tafazzin gene knockdown in cardiac myocytes.
|
| He Q, Harris N, Ren J, Han X.
|
| Oxid Med Cell Longev 2014:654198. doi: 10.1155/2014/654198. Epub 2014 Aug 27.
2014
|
| 11 | BTHS, TAZ
|
| Tafazzin splice variants and mutations in Barth syndrome.
|
| Kirwin SM, Manolakos A, Barnett SS, Gonzalez IL.
|
| Mol Genet Metab 111(1):26-32. doi: 10.1016/j.ymgme.2013.11.006. Epub 2013 Nov 19.
2014
|
| 12 | BHTS, TAZ
|
| Tafazzin knockdown interrupts cell cycle progression in cultured neonatal ventricular fibroblasts.
|
| He Q, Wang M, Harris N, Han X.
|
| Am J Physiol Heart Circ Physiol 305(9):H1332-43. doi: 10.1152/ajpheart.00084.2013. Epub 2013 Aug 30.
2013
|
| 13 | TAZ
|
| Diminished Exercise Capacity and Mitochondrial bc1 Complex Deficiency in Tafazzin-Knockdown Mice.
|
| Powers C, Huang Y, Strauss A, Khuchua Z.
|
| Front Physiol 4:74. doi: 10.3389/fphys.2013.00074. eCollection 2013.
2013
|
| 14 | BHTS, TAZ
|
| Barth syndrome: cellular compensation of mitochondrial dysfunction and apoptosis inhibition due to changes in cardiolipin remodeling linked to tafazzin (TAZ) gene mutation.
|
| Gonzalvez F, D'Aurelio M, Boutant M, Moustapha A, Puech JP, Landes T, Arnauné-Pelloquin L, Vial G, Taleux N, Slomianny C, Wanders RJ, Houtkooper RH, Bellenguer P, Møller IM, Gottlieb E, Vaz FM, Manfredi G, Petit PX.
|
| Biochim Biophys Acta 1832(8):1194-206. doi: 10.1016/j.bbadis.2013.03.005. Epub 2013 Mar 20.
2013
|
| 15 | TAZ
|
| Cardiolipin remodeling and the function of tafazzin.
|
| Schlame M.
|
| Biochim Biophys Acta 1831(3):582-8. doi: 10.1016/j.bbalip.2012.11.007. Epub 2012 Nov 28. Review.
2013
|
| 16 | PTPN11, TAZ, YAP1
|
| YAP and TAZ, Hippo signaling targets, act as a rheostat for nuclear SHP2 function.
|
| Tsutsumi R, Masoudi M, Takahashi A, Fujii Y, Hayashi T, Kikuchi I, Satou Y, Taira M, Hatakeyama M.
|
| Dev Cell 26(6):658-65. doi: 10.1016/j.devcel.2013.08.013. Epub 2013 Sep 12.
2013
|
| 17 | BTHS, TAZ
|
| Seven functional classes of Barth syndrome mutation.
|
| Whited K, Baile MG, Currier P, Claypool SM.
|
| Hum Mol Genet 22(3):483-92. doi: 10.1093/hmg/dds447. Epub 2012 Oct 24.
2013
|
| 18 | TAZ
|
| TAZ is downregulated by dexamethasone during the differentiation of 3T3-L1 preadipocytes.
|
| He Q, Huang HY, Zhang YY, Li X, Qian SW, Tang QQ.
|
| Biochem Biophys Res Commun 419(3):573-7. doi: 10.1016/j.bbrc.2012.02.074. Epub 2012 Feb 20.
2012
|
| 19 | TAZ
|
| The physical state of lipid substrates provides transacylation specificity for tafazzin.
|
| Schlame M, Acehan D, Berno B, Xu Y, Valvo S, Ren M, Stokes DL, Epand RM.
|
| Nat Chem Biol 8(10):862-9.
2012
|
| 20 | TAZ
|
| Tafazzin regulates human conjunctiva epithelial cell proliferation via inhibiting TGFβ signaling pathway.
|
| Tan XW, Beuerman RW, Poh CK, Mehta JS.
|
| Mol Vis 18:1402-10. Epub 2012 Jun 1.
2012
|
| 21 | TAZ
|
| Role of TAZ as mediator of Wnt signaling.
|
| Azzolin L, Zanconato F, Bresolin S, Forcato M, Basso G, Bicciato S, Cordenonsi M, Piccolo S.
|
| Cell 151(7):1443-56. doi: 10.1016/j.cell.2012.11.027. Epub 2012 Dec 13.
2012
|
| 22 | NEK8, NPHP4, TAZ
|
| The ciliopathy disease protein NPHP9 promotes nuclear delivery and activation of the oncogenic transcriptional regulator TAZ.
|
| Habbig S, Bartram MP, Sägmüller JG, Griessmann A, Franke M, Müller RU, Schwarz R, Hoehne M, Bergmann C, Tessmer C, Reinhardt HC, Burst V, Benzing T, Schermer B.
|
| Hum Mol Genet 21(26):5528-38. doi: 10.1093/hmg/dds408. Epub 2012 Oct 1.
2012
|
| 23 | BTHS, TAZ
|
| Cardiac and skeletal muscle defects in a mouse model of human Barth syndrome.
|
| Acehan D, Vaz F, Houtkooper RH, James J, Moore V, Tokunaga C, Kulik W, Wansapura J, Toth MJ, Strauss A, Khuchua Z.
|
| J Biol Chem 286(2):899-908. Epub 2010 Nov 9.
2011
|
| 24 | BTHS, TAZ
|
| Barth syndrome mutations that cause tafazzin complex lability.
|
| Claypool SM, Whited K, Srijumnong S, Han X, Koehler CM.
|
| J Cell Biol 192(3):447-62.
2011
|
| 25 | PPP1CA, TAZ, TP53BP2
|
| PP1 cooperates with ASPP2 to dephosphorylate and activate TAZ.
|
| Liu CY, Lv X, Li T, Xu Y, Zhou X, Zhao S, Xiong Y, Lei QY, Guan KL.
|
| J Biol Chem 286(7):5558-66. doi: 10.1074/jbc.M110.194019. Epub 2010 Dec 28.
2011
|
| 26 | BTHS, TAZ
|
| Gonadal mosaicism of a TAZ (G4.5) mutation in a Japanese family with Barth syndrome and left ventricular noncompaction.
|
| Chang B, Momoi N, Shan L, Mitomo M, Aoyagi Y, Endo K, Takeda I, Chen R, Xing Y, Yu X, Watanabe S, Yoshida T, Kanegane H, Tsubata S, Bowles NE, Ichida F, Miyawaki T; Noncompaction study collaborators.
|
| Mol Genet Metab 100(2):198-203. Epub 2010 Mar 2.PMID: 20303308 2010
|
| 27 | TAZ, TJP1, TJP2
|
| TAZ interacts with zonula occludens-1 and -2 proteins in a PDZ-1 dependent manner.
|
| Remue E, Meerschaert K, Oka T, Boucherie C, Vandekerckhove J, Sudol M, Gettemans J.
|
| FEBS Lett 584(19):4175-80. Epub 2010 Sep 18.
2010
|
| 28 | CCAR1, TAZ
|
| A novel mechanism of cell growth regulation by Cell Cycle and Apoptosis Regulatory Protein (CARP)-1.
|
| Jiang Y, Puliyappadamba VT, Zhang L, Wu W, Wali A, Yaffe MB, Fontana JA, Rishi AK.
|
| J Mol Signal 5:7.
2010
|
| 29 | INADL, PKD2, TAZ
|
| Polycystin-2 activity is controlled by transcriptional coactivator with PDZ binding motif and PALS1-associated tight junction protein.
|
| Duning K, Rosenbusch D, Schlüter MA, Tian Y, Kunzelmann K, Meyer N, Schulze U, Markoff A, Pavenstädt H, Weide T.
|
| J Biol Chem 285(44):33584-8. Epub 2010 Sep 10.
2010
|
| 30 | TAZ
|
| Characterization of tafazzin splice variants from humans and fruit flies.
|
| Xu Y, Zhang S, Malhotra A, Edelman-Novemsky I, Ma J, Kruppa A, Cernicica C, Blais S, Neubert TA, Ren M, Schlame M.
|
| J Biol Chem 284(42):29230-9. Epub 2009 Aug 21.PMID: 19700766 2009
|
| 31 | MED15, TAZ
|
| TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal.
|
| Varelas X, Sakuma R, Samavarchi-Tehrani P, Peerani R, Rao BM, Dembowy J, Yaffe MB, Zandstra PW, Wrana JL.
|
| Nat Cell Biol 10(7):837-48. Epub 2008 Jun 22.
2008
|
| 32 | FGF2, TAZ
|
| FGF-2 signaling induces downregulation of TAZ protein in osteoblastic MC3T3-E1 cells.
|
| Eda H, Aoki K, Marumo K, Fujii K, Ohkawa K.
|
| Biochem Biophys Res Commun 366(2):471-5. Epub 2007 Dec 5.
2008
|
| 33 | BTHS, TAZ
|
| Comparison of lymphoblast mitochondria from normal subjects and patients with Barth syndrome using electron microscopic tomography.
|
| Acehan D, Xu Y, Stokes DL, Schlame M.
|
| Lab Invest 87(1):40-8. Epub 2006 Oct 16.
2007
|
| 34 | LDB3, TAZ
|
| Barth syndrome associated with compound hemizygosity and heterozygosity of the TAZ and LDB3 genes.
|
| Marziliano N, Mannarino S, Nespoli L, Diegoli M, Pasotti M, Malattia C, Grasso M, Pilotto A, Porcu E, Raisaro A, Raineri C, Dore R, Maggio PP, Brega A, Arbustini E.
|
| Am J Med Genet A 143A(9):907-15.
2007
|
| 35 | BTHS, TAZ
|
| Monolysocardiolipin in cultured fibroblasts is a sensitive and specific marker for Barth Syndrome.
|
| van Werkhoven MA, Thorburn DR, Gedeon AK, Pitt JJ.
|
| J Lipid Res 47(10):2346-51. Epub 2006 Jul 27.
2006
|
| 36 | BTHS, TAZ
|
| Mitochondrial respiratory chain supercomplexes are destabilized in Barth Syndrome patients.
|
| McKenzie M, Lazarou M, Thorburn DR, Ryan MT.
|
| J Mol Biol 361(3):462-9. Epub 2006 Jul 5.
2006
|
| 37 | BTHS, TAZ
|
| Taz1, an outer mitochondrial membrane protein, affects stability and assembly of inner membrane protein complexes: implications for Barth Syndrome.
|
| Brandner K, Mick DU, Frazier AE, Taylor RD, Meisinger C, Rehling P.
|
| Mol Biol Cell 16(11):5202-14. Epub 2005 Aug 31. 2005
|
| 38 | BTHS, TAZ
|
| Barth syndrome: TAZ gene mutations, mRNAs, and evolution.
|
| Gonzalez IL.
|
| Am J Med Genet A 134(4):409-14.
2005
|
| 39 | TAZ, DTNA, INVM, LVNC
|
| Isolated left ventricular noncompaction is rarely caused by mutations in G4.5, alpha-dystrobrevin and FK Binding Protein-12.
|
| Kenton AB, Sanchez X, Coveler KJ, Makar KA, Jimenez S, Ichida F, Murphy RT, Elliott PM, McKenna W, Bowles NE, Towbin JA, Bowles KR.
|
| Mol Genet Metab 82(2):162-6. 2004
|
| 40 | TAZ, NKX2-1
|
| TAZ interacts with TTF-1 and regulates expression of surfactant protein-C.
|
| Park KS, Whitsett JA, Di Palma T, Hong JH, Yaffe MB, Zannini M.
|
| J Biol Chem 279(17):17384-90. Epub 2004 Feb 17. 2004
|
| 41 | BTHS, TAZ
|
| Complex expression pattern of the Barth syndrome gene product tafazzin in human cell lines and murine tissues.
|
| Lu B, Kelher MR, Lee DP, Lewin TM, Coleman RA, Choy PC, Hatch GM.
|
| Biochem Cell Biol 82(5):569-76. 2004
|
| 42 | TAZ
|
| A novel mutation in the G4.5 (TAZ) gene in a kindred with Barth syndrome.
|
| Vesel S, Stopar-Obreza M, Trebusak-Podkrajsek K, Jazbec J, Podnar T, Battelino T.
|
| Eur J Hum Genet 11(1):97-101. 2003
|
| 43 | TAZ, BTHS
|
| Only one splice variant of the human TAZ gene encodes a functional protein with a role in cardiolipin metabolism.
|
| Vaz FM, Houtkooper RH, Valianpour F, Barth PG, Wanders RJ.
|
| J Biol Chem 278(44):43089-94. Epub 2003 Aug 20. Erratum in: J Biol Chem. 2004 Jun 18;279(25):26802. 2003
|
| 44 | INVM, TAZ
|
| Mutation analysis of the G4.5 gene in patients with isolated left ventricular noncompaction.
|
| Chen R, Tsuji T, Ichida F, Bowles KR, Yu X, Watanabe S, Hirono K, Tsubata S, Hamamichi Y, Ohta J, Imai Y, Bowles NE, Miyawaki T, Towbin JA.
|
| Mol Genet Metab 77(4):319-25. 2002
|
| 45 | TAZ
|
| A novel intronic mutation of the TAZ ( G4.5) gene in a patient with Barth syndrome: creation of a 5' splice donor site with variant GC consensus and elongation of the upstream exon.
|
| Sakamoto O, Ohura T, Katsushima Y, Fujiwara I, Ogawa E, Miyabayashi S, Iinuma K.
|
| Hum Genet 109(5):559-63. 2001
|
| 46 | BTHS2, DTNA, BTHS, LVNC, TAZ
|
| Novel gene mutations in patients with left ventricular noncompaction or Barth syndrome.
|
| Ichida F, Tsubata S, Bowles KR, Haneda N, Uese K, Miyawaki T, Dreyer WJ, Messina J, Li H, Bowles NE, Towbin JA.
|
| Circulation 103(9):1256-63. 2001
|
| 47 | CMD1L, LGMD2F, SGCD, TAZ
|
| Mutations in the human delta-sarcoglycan gene in familial and sporadic dilated cardiomyopathy.
|
| Tsubata S, Bowles KR, Vatta M, Zintz C, Titus J, Muhonen L, Bowles NE, Towbin JA.
|
| J Clin Invest 106(5):655-62. 2000
|
| 48 | TAZ
|
| Selection and mapping of replication origins from a 500-kb region of the human X chromosome and their relationship to gene expression.
|
| Rivella S, Palermo B, Pelizon C, Sala C, Arrigo G, Toniolo D.
|
| Genomics 62(1):11-20 1999
|
| 49 | CMD3A, BTHS, INVM, TAZ
|
| The X-linked gene G4.5 is responsible for different infantile dilated cardiomyopathies.
|
| D'Adamo P, Fassone L, Gedeon A, Janssen EA, Bione S, Bolhuis PA, Barth PG, Wilson M, Haan E, Orstavik KH, Patton MA, Green AJ, Zammarchi E, Donati MA, Toniolo D.
|
| Am J Hum Genet 61(4):862-7. 1997
|
| 50 | INVM, TAZ
|
| Neonatal, lethal noncompaction of the left ventricular myocardium is allelic with Barth syndrome.
|
| Bleyl SB, Mumford BR, Thompson V, Carey JC, Pysher TJ, Chin TK, Ward K.
|
| Am J Hum Genet 61(4):868-72. 1997
|
| 51 | BTHS, TAZ
|
| Mutation characterization and genotype-phenotype correlation in Barth syndrome.
|
| Johnston J, Kelley RI, Feigenbaum A, Cox GF, Iyer GS, Funanage VL, Proujansky R.
|
| Am J Hum Genet 61(5):1053-8. 1997
|
| 52 | TAZ
|
| A novel X-linked gene, G4.5. is responsible for Barth syndrome.
|
| Bione S, et al.
|
| Nat Genet 12 : 385-389. 1996
|
| 53 | G6PD, ERVK2, ERVK3, DDB1, TAZ, ATP6AP1, GDI1, FAM50A, FAM3A, PLXNA3, ATP6AP1
|
| Construction of a transcription map of a 300 kb region around the human G6PD locus by direct cDNA selection.
|
| Sedlacek Z, Korn B, Konecki DS, Siebenhaar R, Coy JF, Kioschis P, Poustka A.
|
| Hum Mol Genet 2(11):1865-9. 1993
|